These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2500599)

  • 21. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
    Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
    J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction, expression and the characterization of t-PA mutants with increased plasma half-life and resistance to inhibition by PAI-1.
    Liu S; Huang P; Huang C
    Chin J Biotechnol; 1995; 11(1):17-25. PubMed ID: 7548767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
    De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ
    Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors.
    Gils A; Declerck PJ
    Thromb Haemost; 2004 Mar; 91(3):425-37. PubMed ID: 14983217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitution of serine or threonine at position 473 of tissue-type plasminogen activator increases its stability in plasma.
    Alibhai M; Chow AM; Paoni NF
    Thromb Haemost; 1996 Jan; 75(1):107-12. PubMed ID: 8713788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1994 Dec; 72(6):893-9. PubMed ID: 7740460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates.
    Stürzebecher J; Neumann U; Kohnert U; Kresse GB; Fischer S
    Protein Sci; 1992 Aug; 1(8):1007-13. PubMed ID: 1304379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
    Hayashi T
    Rinsho Byori; 1994 Apr; 42(4):346-51. PubMed ID: 8176842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites].
    Zhu MC; Zhan Z; Wang YJ; Liu CG; Shi Y; Cai Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):565-9. PubMed ID: 16143058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.
    Tachias K; Madison EL
    J Biol Chem; 1997 Jun; 272(23):14580-5. PubMed ID: 9169416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of latency in plasminogen activator inhibitor-1.
    Mottonen J; Strand A; Symersky J; Sweet RM; Danley DE; Geoghegan KF; Gerard RD; Goldsmith EJ
    Nature; 1992 Jan; 355(6357):270-3. PubMed ID: 1731226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel variant of t-PA resistant to plasminogen activator inhibitor-1; expression in CHO cells based on in silico experiments.
    Davami F; Sardari S; Majidzadeh-A K; Hemayatkar M; Barkhordari F; Enayati S; Adeli A; Mahboudi F
    BMB Rep; 2011 Jan; 44(1):34-9. PubMed ID: 21266104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Erythrina protease inhibitor: interactions with tissue plasminogen activator.
    Heussen-Schemmer C; Merrifield EH; Dowdle EB
    Thromb Haemost; 1991 Aug; 66(2):226-31. PubMed ID: 1771616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of serine protease-inhibitor interaction by protein engineering.
    Madison EL; Goldsmith EJ; Gething MJ; Sambrook JF; Gerard RD
    J Biol Chem; 1990 Dec; 265(35):21423-6. PubMed ID: 2123870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.